The report offers detailed coverage of Fosfomycin Trometamol industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Fosfomycin Trometamol by geography. The report splits the market size, by volume and value, on the basis of application type and geography.
Fosfomycin tromethamine, white or almost white crystalline powder; odorless, taste salty; Very soluble in water, dissolved in methanol, very slightly soluble in ethanol, insoluble in chloroform.
Mainly for the treatment of urinary tract infections such as cystitis, urethritis.
In the last several years, global market of fosfomycin trometamol developed smoothly, with an average growth rate of 7.8%. In 2015, global revenue of fosfomycin trometamol is nearly 44 million usd; the actual production is about 354 MT.
the global average price of fosfomycin trometamol is in the decreasing trend, from 131 USD /kg in 2011 to 124 USD/kg in 2015. with the situation of global economy, prices will be in decreasing trend in the following five years.
the classification of fosfomycin trometamol includes fosfomycin tromethamine granules and fosfomycin tromethamine powder, and the proportion of fosfomycin tromethamine granules in 2015 is about 56%.fosfomycin trometamol is widely used in urinary tract infection.
china is the largest supplier of fosfomycin trometamol, with a production market share nearly 83% in 2015. europe is the second largest supplier of fosfomycin trometamol, enjoying production market share nearly 15% in 2015.
north america is the largest consumption place, with a consumption market share nearly 36% in 2015. following north america, europe is the second largest consumption place with the consumption market share of 31%. China is the world's largest exporting country.
market competition is not intense. Zambon and northesat pharm, are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
The report forecast global Fosfomycin Trometamol market to grow to reach xxx Million USD in 2020 with a CAGR of xx% during the period 2021-2025.
First, this report covers the present status and the future prospects of the global Fosfomycin Trometamol market for 2015-2025.
And in this report, we analyze global market from 5 geographies: Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia], Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland], North America[United States, Canada, Mexico], Middle East & Africa[GCC, North Africa, South Africa], South America[Brazil, Argentina, Columbia, Chile, Peru].
Key Companies
Zambon
Northesat Pharm
Hunan Huana Pharmaceuticals
Xunda Pharma
FarmaSino Pharmaceutical
Guilin Hwasun
At the same time, we classify Fosfomycin Trometamol according to the type, application by geography. More importantly, the report includes major countries market based on the type and application.
Market Segment as follows:
Market by Order Type
Fosfomycin Tromethamine Granules
Fosfomycin Tromethamine Powder
Market by Application
Common Urinary Tract Infection
Postoperative Urinary Tract Infection
Preoperative Prevention of Urinary Tract Infection
By Region
Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia]
Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
North America[United States, Canada, Mexico]
Middle East & Africa[GCC, North Africa, South Africa]
South America[Brazil, Argentina, Columbia, Chile, Peru]
The research provides answers to the following key questions:
• What is the estimated growth rate and market share and size of the Fosfomycin Trometamol market for the forecast period 2021 - 2025?
• What are the driving forces in the Fosfomycin Trometamol market for the forecast period 2021 - 2025?
• Who are the prominent market players and how have they gained a competitive edge over other competitors?
• What are the market trends influencing the progress of the Fosfomycin Trometamol industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the market hold for the prominent market players?